ReviewLife (Basel, Switzerland)2026
Dexmedetomidine as an Adjunct to Transversus Abdominis Plane Block in Patients Undergoing Cancer Surgeries: A Systematic Review and Meta-Analysis.
Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer rates are increasing significantly worldwide, with surgical intervention being the most convenient intervention. Transversus abdominis plane (TAP) block has been proven to enhance postoperative opioid use and its associated complications. Additionally, dexmedetomidine has been reported to provide effective analgesia with relatively minimal respiratory complications. This systematic review and meta-analysis aims to explore the efficacy of combining dexmedetomidine with transversus abdominis plane (TAP) block compared to transversus abdominis plane (TAP) block alone in patients undergoing various cancer surgeries as outcomes may also be influenced by surgical and patient-related factors.
methodsWe conducted a comprehensive literature search across PubMed/MEDLINE, Scopus, Web of Science, Cochrane CENTRAL, and Embase to identify randomized controlled trials evaluating the efficacy and safety of dexmedetomidine as an adjunct to transversus abdominis plane (TAP) block in patients undergoing cancer surgery. Data were extracted from the six eligible randomized controlled trials that met the predefined inclusion criteria, and a random-effects meta-analysis was performed using RevMan software Version 5.4.
resultsThe meta-analysis found that dexmedetomidine as an adjunct to transversus abdominis plane (TAP) block was more effective than transversus abdominis plane (TAP) block alone in reducing the mean arterial pressure and the mean heart rate 2 h postoperatively (MD -6.46, 95% CI [-8.63; -4.30],
conclusionsCompared to transversus abdominis plane (TAP) block alone, the dexmedetomidine and transversus abdominis plane (TAP) block arm showed a statistically significant difference in time to first rescue analgesia, patient overall satisfaction, nausea, and vomiting. However, no statistical significance difference was found across the remaining outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.